#Oberoirlty:(NSE)Buy:509 | T1:512| T2:516| T3:519| SL: 506
#Graphite:(NSE)BUY:332 | T1:335| T2:338| T341:| SL: 329
Intraday tips for 14th May,2019
#Dhfl:(NSE)Sell:110 or BELOW | T1:108| T2:106| T3:104| SL: 112
#Tatamotors:(NSE)SELL:180 | T1:177| T2:174| T3:171| SL: 183
Intraday tips for 13th May,2019
#Cadilahc:(NSE)Sell:289 or BELOW | T1:286| T2:283| T3:280| SL: 292
#Escorts:(NSE)SELL:597 | T1:594| T2:591| T3:588| SL: 600
Intraday tips for 10th May,2019
#Bergerpaint:(NSE):Buy: 302.50 | T1:305| T2:308| T3:311| SL: 299
#Auropharma:(NSE)Buy:757| T1:760| T2:763| T3:766| SL:754
#Axisbank:(NSE):Buy: 733 | T1:736| T2:739| T3:742| SL: 730
#JSWSTEEL:(NSE)Buy:287| T1:290| T2:293| T3:296| SL:284
Par Drugs Limited SME IPO Details
Par Drugs Limited incorporated in 1999 based in Gujarat. The company manufacturers more then 18 diffrent products and all the requisite grades as available in market. The products they manufacture are Magnesium Salts, Blended, Dried Aluminum Hydroxide Gel, Amorphous, Silicates, Precipitated Silica, Collodial Silicon Dioxide, Sucralfate USP, Sodium Aluminium Silicate. Their products are manufacture for Indian and International markets as well. They have manufacturing facilities in Ankleshwar and Bhavnagar. They have 6 fine chemical and 12 API products used in 17 countries. The major customers are Dabur India, Meyer Organics, Cadila Healthcare, Cipla, Pfizer and more. Par Drugs ipo is a NSE SME IPO. Par Drugs ipo is starting from 03-May and ends on 08-May. The price band is around ₹51 with 2000 market lot. The ipo size is around ₹8.53 rupees.
Par Drugs IPO Review:
- Risky
Par Drugs IPO Dates & Price Band:
- IPO Open: 03-May-2019
- IPO Close: 08-May-2019
- IPO Size: Approx ₹8.53 Crore
- Face Value: ₹10 Per Equity Share
- Price Band: ₹51 Per Equity Share
- Listing on: NSE SME
- Shares: 1,672,000
- Retail Portion: 50%
Par Drugs IPO Market Lot:
- Shares: Apply for 2,000 Shares (Minimum Lot Size)
- Amount: ₹1,02,000
Par Drugs IPO Allotment & Listing:
- Basis of Allotment: 13-May-2019
- Refunds: 14-May-2019
- Credit to demat accounts: 15-May-2019
- Listing: 16-May-2019
Financial Results:
| ₹ in Crore | |||||
| Revenue | Expenses | PAT | |||
| 2015 | - | - | - | ||
| 2016 | - | - | - | ||
| 2017 | 48.81 | 45.63 | 1.85 | ||
| 2018 | 42.42 | 39.86 | 1.50 | ||
| 2019 | 46.41 | 43.13 | 2.42 | ||
Par Drugs IPO Allotment Status:
Company Promoters:
- Falgun Vallabhbhai Savani
- Jignesh Vallabhbhai Savani
IPO Registrar:
Link Intime India Private Ltd
C 101, 247 Park, L.B.S.Marg,
Vikhroli (West), Mumbai - 400083
Phone: +91-22-4918 6270
Email: pardrugs.ipo@linkintime.co.in
Website: http://www.linkintime.co.in
IPO Lead Managers:
- PANTOMATH CAPITAL ADVISORS PRIVATE LIMITED
Company Address:
Par Drugs and Chemicals Limited
805, Dwarkesh Complex,
R.C. Dutt Road,
Alkapuri, Vadodara-390 007,
Phone: +91 265 2332018
Email: cs.sanket@pardrugs.com
Website: http://pardrugs.com
Cian Healthcare Limited SME IPO Details
Cian Healthcare Limited incorporated in 2003 based in Pune. The company is fully integrated pharmaceutical company committed to bring innovative and affordable medicines to address patient needs. The product range used in gynaecology, haematinic,cardio- diabetic, orthopaedic, paediatric, derma-cosmetic, antibiotic, CNS, vitamins & nutrient products. The company is certified by WHO-GMP & ISO 9001:2015. The manufacturing process company with WHO rules and regulations. The product includes Sachet, Gels, Lotions, Creams, Ointments, Liquid Orals, Capsules and Tablets. They also owns a special licence to manufacture veterinary products such as Venky's and SAVAvet. Cian Healthcare ipo is a BSE SME IPO. Cian Healthcare ipo is starting from 02-May and ends on 09-May. The price band is around ₹61-65 with 2000 market lot. The ipo size is around ₹40.00 crore rupees.
Cian Healthcare IPO Review:
- Good for Long Term
Cian Healthcare IPO Dates & Price Band:
- IPO Open: 02-May-2019
- IPO Close: 09-May-2019
- IPO Size: Approx ₹40.00 Crore
- Face Value: ₹10 Per Equity Share
- Price Band: ₹61-65 Per Equity Share
- Listing on: BSE SME
- Shares: 6,216,000
- Retail Portion: 50%
Cian Healthcare IPO Market Lot:
- Shares: Apply for 2,000 Shares (Minimum Lot Size)
- Amount: ₹1,30,000
Cian Healthcare IPO Allotment & Listing:
- Basis of Allotment: 14-May-2019
- Refunds: 15-May-2019
- Credit to demat accounts: 16-May-2019
- Listing: 17-May-2019
Financial Results:
| ₹ in Crore | |||||
| Revenue | Expenses | PAT | |||
| 2015 | - | - | - | ||
| 2016 | 47.16 | 45.00 | 1.37 | ||
| 2017 | 51.85 | 48.77 | 2.24 | ||
| 2018 | 59.59 | 54.46 | 3.76 | ||
| 2019 (9M) | 44.48 | 37.23 | 5.25 | ||
Cian Healthcare IPO Allotment Status:
Company Promoters:
- Suraj Zanwar
- Kavita Zanwar
IPO Registrar:
Bigshare Services Private Limited
E2, Ansa Industrial Estate, Sakivihar Road,
Sakinaka, Andheri (E)
Mumbai – 400 072
Phone: +91 22 4043 0200
Fax: +91 22 2847 5201
Email: ipo@bigshareonline.com
Website: www.bigshareonline.com
IPO Lead Managers:
- Fedex Securities Limited
Company Address:
Cian Healthcare Limited
Milkat No. 3339, Block No.1,
From South Side, C.S.No.227 /2 + 3A, Harpale Park,
Opp Berger Paint, Phursungi, Pune- 412308
Phone: 020-41471234 /265
Email: cs@cian.co
Website: https://www.cian.co
Intraday tips for 8th May,2019
Market may fall today due to worst US market.
#Biocon:(NSE):Buy: 592 or above | T1:595| T2:598| T3:601| SL: 589
Intraday tips for 7th May,2019
#Mfsl:(NSE):Buy: 425 or above | T1:428| T2:431| T3:434| SL: 422
#Adaniports:(NSE)Buy:380.5 | T1:384| T2:387| T3:390| SL: 378
#Rblbank:(NSE):Buy: 668.7 or above | T1:672| T2:675| T3:678| SL: 665.7
#TechM:(NSE)Buy:823 | T1:826| T2:829| T3:832| SL: 820
Intraday tips for 6th May,2019
#TataMotors:(NSE)Sell:209 or BELOW | T1:206| T2:203| T3:200| SL: 212
#DLF:(NSE)Buy:178 | T1:181| T2:184| T3:187| SL: 175
Intraday tips for 3rd May,2019
Lupin:(NSE)BUY:878| T1:881| T2:884| T3:887| SL: 875
#Sunpharma:(NSE)SELL:452 or BELOW | T1:449| T2:446| T3:443| SL: 455
